Dala Group
ABBV icon

Dala Group’s AbbVie ABBV Stock Holding History

Dala Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$353K Buy
1,348
+10
+0.7% +$2.56K 0.26% 46
2026
Q2 		$337K Sell
1,338
-26
-2% -$5.59K 0.28% 48
2026
Q1 		$297K Buy
1,364
+10
+0.7% +$2.22K 0.25% 56
2025
Q4 		$309K Buy
+1,354
New +$308K 0.27% 55

Other funds holding ABBV

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return
Asset Management One
Asset Management One Tokyo, Japan $40B AUM 30.45% 1-Year Est. Return
B. Metzler seel. Sohn & Co
B. Metzler seel. Sohn & Co Frankfurt, Germany $11.5B AUM 29.17% 1-Year Est. Return

Dala Group's ABBV Position: Q3 2026 in Review

Dala Group increased its AbbVie (ABBV) stake by 0.75% in Q3 2026, buying an estimated $2.56K and bringing the position to 1,348 shares worth $353K. The position accounts for 0.26% of the portfolio, ranked #46.

Dala Group first reported a position in ABBV in Q4 2025 and has held it in 4 quarters since. 1,999 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Dala Group held 1,348 shares of AbbVie worth $353K as of Q3 2026.
  • Dala Group bought 10 AbbVie shares in Q3 2026, an estimated $2.56K.
  • AbbVie made up 0.26% of Dala Group's portfolio in Q3 2026, its #46 holding.
  • Dala Group first reported a position in AbbVie in Q4 2025 and has held it in 4 quarters since.
  • 1,999 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Dala Group's 13F filing for Q3 2026, filed 29 Oct 2026.